The effect of clarithromycin on inflammatory markers in chronic obstructive pulmonary disease: Preliminary data

BAŞYİĞİT İ., YILDIZ F. F., ÖZKARA S., YILDIRIM E., BOYACI H., ILGAZLI A. H.

ANNALS OF PHARMACOTHERAPY, cilt.38, sa.9, ss.1400-1405, 2004 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 38 Sayı: 9
  • Basım Tarihi: 2004
  • Doi Numarası: 10.1345/aph.1d634
  • Dergi Adı: ANNALS OF PHARMACOTHERAPY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.1400-1405
  • Kocaeli Üniversitesi Adresli: Evet

Özet

BACKGROUND: Clarithromycin is an antimicrobial agent that can be used for treatment of chronic obstructive pulmonary disease (COPD) exacerbations with bronchodilator therapy. However, it has also been shown that clarithromycin has antiinflammatory effects by the inhibition of cytokine production.